SSRIs are standard for pediatric OCD, but how much do they actually move the needle? An individual participant data meta-analysis puts a number on it, and the answer is more nuanced than the guidelines suggest. Baseline severity, it turns out, matters more than most clinicians realize.

Side effects are the most common reason kids stop antidepressants, yet most monitoring tools are too cumbersome for real-world visits. The FIBSER-C asks just three questions and takes under a minute. Could this be the side effect check-in your practice has been missing?

SSRIs are among the most prescribed medications in adolescents, but are we paying close enough attention to what they may be doing to pubertal growth? A prospective cohort study found dose-related reductions in height velocity, with changes in growth hormone signaling suggesting a possible biologic mechanism.

When family-based therapy stalls in adolescents with anorexia, what comes next? A retrospective matched-cohort study suggests that low-dose aripiprazole may loosen cognitive rigidity enough to get treatment moving again — with doses averaging under 3 mg/day and a surprisingly favorable side-effect profile.

Antipsychotics can be very effective for irritability in autism, but they are often unnecessary, and the side effects are truly problematic. Don’t be the prescriber who hears irritability in autism and immediate prescribes antipsychotics. There are usually multiple steps to try before using the FDA approved antipsychotic medications.